Walgreens stock price forecast remains sensitive to healthcare policy changes, with regulatory clarity likely to lift sentiment, offering a pathway toward a $22.80 short-term price target. Prior to today's trading, shares of the largest U.S. drugstore chain had gained 33.33% over the past month. This has outpaced the Retail-Wholesale sector's gain of 6.63% and the S&P 500's gain of 5.28% in that time. Analysts who follow Walgreens see the move to private ownership as another plus because the company and a stock price attached to public ownership will no longer be subject to the whims of Wall Street. Walgreens stock price forecast remains supported by improving script counts and consumer healthcare demand, key drivers of steady revenue growth.
